Softgel Capsules Market Analysis

Softgel Capsules Market Analysis

Based on type, the gelatin-based softgel capsules market was valued at around USD 8 billion in 2022. Owing to their superior pH-dependent gelling and thermo-reversibility properties, gelatin-based capsules are easy to manufacture. They help improve the bioavailability of poorly water-soluble active ingredients, which contributes to the overall drug effectiveness. Additionally, they demonstrate excellent versatility, allowing manufacturers to customize the capsules based on shape, color, and other attributes, favoring their adoption through 2032.
 

Based on the manufacturer, the nutraceutical companies segment will surpass USD 6.8 billion by 2032. Surging incidences of osteoarthritis have augmented the demand for nutraceuticals made of herbs to counter the effects of inflammation. Growing health awareness has further bolstered the demand for nutraceutical supplements, supplementing segment growth.  Furthermore, the increasing number of nutraceutical companies across the globe is creating a notable impetus for segment growth.
 

North America softgel capsules market size will reach over USD 3.9 billion by 2032. Surging prevalence of chronic disorders has increased the demand for softgel capsules in the region. The regional expansion can also be credited to growing healthcare expenditure, in line with the robust presence of leading softgel manufacturers such as Captek Softgel International Inc., Catalent Inc., and others. Moreover, growing health awareness has further bolstered the demand for health supplements in the region, supporting product uptake.